Targeting Normoxia in Neonates With Cyanotic Congenital Heart Disease in the Intra-operative and Immediate Post-operative Period (T-NOX)
Targeting Normoxia in Neonates With Cyanotic Congenital Heart Disease in the Intra-operative and Immediate Post-operative Period (T-NOX)
Sponsor: National Center for Advancing Translational Sciences (NCATS)
Listed as NCT04452188, this NA trial focuses on Cardiopulmonary Bypass and Double Outlet Right Ventricle With Subaortic Ventricular Septal Defect and Pulmonary Stenosis and remains completed. Sponsored by National Center for Advancing Translational Sciences (NCATS), it has been updated 10 times since 2021, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Aug 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Jul 2023 — Aug 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jul 2022 — Jul 2023 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Nov 2021 — Jul 2022 [monthly]
Recruiting NA
-
Feb 2021 — Nov 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Jul 2020 — Oct 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Center for Advancing Translational Sciences (NCATS)
- National Institutes of Health (NIH)
- University of Michigan
For direct contact, visit the study record on ClinicalTrials.gov .